𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical outcome and tolerability of Duloxetine in the treatment of major depressive disorder: A 12-week study with plasma levels

✍ Scribed by L.S. Volonteri; G. Cerveri; A. Colasanti; I. De Gaspari; M.C. Mauri; C. Mencacci

Book ID
118439222
Publisher
Elsevier Science
Year
2008
Tongue
French
Weight
46 KB
Volume
23
Category
Article
ISSN
0924-9338

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Safety and tolerability of duloxetine in
Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials
✍ James I. Hudson; Madelaine M. Wohlreich; Daniel K. Kajdasz; Craig H. Mallinckrod πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 185 KB πŸ‘ 2 views

## Abstract ## Objective To examine the safety and tolerability of the antidepressant duloxetine across multiple studies for major depressive disorder (MDD). ## Method Safety data were integrated from the acute phases of eight double‐blind, placebo‐controlled trials in which patients were random

Duloxetine for the treatment of mood dis
Duloxetine for the treatment of mood disorder in cancer patients: a 12-week case-control clinical trial
✍ Riccardo Torta; Paolo Leombruni; Roberto Borio; Lorys Castelli πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 125 KB πŸ‘ 2 views

Objective The aim of this study was to investigate the efficacy and tolerability of duloxetine in cancer patients with mood disorder (MD) by means of a comparison with a matched control group of patients with MD without medical illness. Methods Fifty-nine consecutive patients with MD were enrolled i